CGS-8216
Chemical compound
| CGS-8216 | |
|---|---|
| [[File:|frameless|220px|alt=|]] | |
| INN | |
| Drug class | |
| Routes of administration | |
| Pregnancy category | |
| Bioavailability | |
| Metabolism | |
| Elimination half-life | |
| Excretion | |
| Legal status | |
| CAS Number | |
| PubChem | |
| DrugBank | |
| ChemSpider | |
| KEGG | |
CGS-8216 is a chemical compound that acts as a benzodiazepine receptor antagonist. It is known for its ability to counteract the effects of benzodiazepines, which are a class of drugs primarily used for treating anxiety, insomnia, and several other conditions.
Pharmacology[edit]
CGS-8216 binds to the GABA A receptor at the same site as benzodiazepines but does not activate the receptor. Instead, it blocks the effects of benzodiazepines, making it useful in research to study the role of GABA A receptors in various physiological and pathological processes.
Mechanism of Action[edit]
The primary mechanism of action of CGS-8216 involves its interaction with the GABA A receptor. By binding to the benzodiazepine site on the receptor, CGS-8216 prevents benzodiazepines from exerting their effects, which include sedation, anxiolysis, and muscle relaxation. This makes CGS-8216 a valuable tool in the study of GABAergic neurotransmission.
Research Applications[edit]
CGS-8216 is widely used in neuroscience research to investigate the role of GABA A receptors in the central nervous system. It has been employed in studies examining the effects of benzodiazepines on memory, anxiety, and seizures. Additionally, CGS-8216 has been used to explore the potential therapeutic applications of benzodiazepine receptor antagonists in conditions such as benzodiazepine overdose and dependence.
Safety and Toxicity[edit]
As with many research chemicals, the safety and toxicity profile of CGS-8216 is not fully understood. It is primarily used in controlled laboratory settings, and its effects in humans have not been extensively studied. Researchers handling CGS-8216 should follow appropriate safety protocols to minimize any potential risks.
See also[edit]
References[edit]
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa
Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
